Genomelink
Other Healthcare Services
Genomelink valuation and funding history | Last updated: December 1, 2021 | 1 funding rounds
Current Valuation
N/A
As of December 1, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC
$4.6M
Last Funding
Dec 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 1, 2021 | Early Stage VC | $4.6M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Genomelink is currently valued at N/A as of December 1, 2021.
What is Genomelink Worth in 2026?
Genomelink is a leading private company in the Other Healthcare Services sector. Track Genomelink's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Genomelink Valuation is Determined
Private company valuations like Genomelink's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.